Pradaxa 150mg Capsule
Marketer
Boehringer Ingelheim
Salt Composition
Dabigatran Etexilate (150mg)
Overview Pradaxa 150mg Capsule
Dabigatran etexilate 150mg capsules are prescribed to thin the blood, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by hindering clot formation in leg, lung, brain, and heart veins. Frequently used for patients with atrial fibrillation (irregular heartbeat), it also mitigates clotting risks post-knee or hip replacement surgery. Administration is independent of food intake, but consistent daily timing is recommended. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage changes require physician approval to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle adjustments—such as abstaining from smoking, adopting a healthy diet, incorporating regular exercise, and managing weight—further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding tendency (e.g., nosebleeds, bruising). Report any adverse effects promptly to your doctor. Other potential side effects involve headaches, seizures, allergic responses, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is inadvisable during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't necessary.
Uses of Pradaxa 150mg Capsule
Managing and averting venous thromboembolism
Major Benefits of Pradaxa 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Pradaxa 150mg capsules can be administered with or without food; however, consistent daily timing is recommended.
Common Side effects of Pradaxa 150mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Pradaxa 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Pradaxa 150mg Capsules can be administered with or without food; however, consistent daily timing is recommended.
How Pradaxa 150mg Capsule works:
Lixiana 150mg capsules represent a new generation of oral blood thinners. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Pradaxa 150mg capsules are contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Pradaxa 150mg capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of 150mg Pradaxa capsules while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by a 150mg Pradaxa capsule.
KidneyCAUTION
Dabigatran etexilate 150mg capsules require careful consideration for patients exhibiting severe renal impairment. Dosage modification may be necessary. Physician consultation is advised. Prescribing dabigatran etexilate 150mg capsules is generally inadvisable for individuals with severe kidney disease.
LiverCAUTION
Dabigatran etexilate 150mg capsules require careful consideration for individuals with hepatic impairment. Dosage modification of the 150mg dabigatran etexilate capsule may be necessary. Physician consultation is advised.
What if you forget to take Pradaxa 150mg Capsule :
Should you forget a Pradaxa 150mg capsule dose, ingest it immediately if still within the same day. However, omit the missed dose if less than six hours remain until your next scheduled intake. Never compensate for a missed dose by taking double the prescribed amount.
Facts to Know About Pradaxa 150mg Capsule
Label | Value |
---|---|
Chemical Type | Benzimidazole-based compound |
Developing Habits | No. |
Treatment Category | Heart |
Action Class | Oral direct thrombin inhibitor |